X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (178653) 178653
Newspaper Article (10958) 10958
Newsletter (9636) 9636
Magazine Article (1983) 1983
Book Chapter (656) 656
Dissertation (600) 600
Web Resource (365) 365
Book / eBook (222) 222
Conference Proceeding (212) 212
Trade Publication Article (175) 175
Reference (108) 108
Publication (84) 84
Book Review (59) 59
Transcript (46) 46
Government Document (25) 25
Journal / eJournal (25) 25
Report (18) 18
Streaming Video (18) 18
Paper (16) 16
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (104560) 104560
science & technology (104165) 104165
life sciences & biomedicine (99557) 99557
male (62775) 62775
animals (55584) 55584
female (51726) 51726
anti-inflammatory agents - therapeutic use (37132) 37132
nonsteroidal anti-inflammatory drugs (29899) 29899
adult (29540) 29540
middle aged (27934) 27934
anti-inflammatory agents, non-steroidal - therapeutic use (27343) 27343
pharmacology & pharmacy (26585) 26585
anti-inflammatory agents - pharmacology (25640) 25640
inflammation (21715) 21715
anti-inflammatory drugs (21463) 21463
rats (20675) 20675
mice (20589) 20589
aged (19470) 19470
anti-inflammatory agents, non-steroidal - pharmacology (17407) 17407
anti-inflammatory agents, non-steroidal - adverse effects (15836) 15836
research (15460) 15460
anti-inflammatory agents - administration & dosage (15291) 15291
treatment outcome (15008) 15008
analysis (12730) 12730
anti-inflammatory agents, non-steroidal - administration & dosage (12600) 12600
anti-inflammatory (10619) 10619
adolescent (10094) 10094
care and treatment (9685) 9685
chemistry (9204) 9204
dose-response relationship, drug (9161) 9161
risk factors (8878) 8878
immunology (8809) 8809
pain (8694) 8694
general & internal medicine (8470) 8470
disease models, animal (8448) 8448
time factors (8434) 8434
physical sciences (8398) 8398
anti-inflammatory agents (8334) 8334
chemistry, medicinal (7816) 7816
biochemistry & molecular biology (7659) 7659
health aspects (7605) 7605
anti-inflammatory agents - adverse effects (7487) 7487
child (7344) 7344
medicine, general & internal (7294) 7294
analgesics (7235) 7235
drug therapy (7222) 7222
inflammation - drug therapy (6995) 6995
drug therapy, combination (6838) 6838
cytokines (6762) 6762
administration, topical (6757) 6757
gastroenterology & hepatology (6681) 6681
double-blind method (6642) 6642
neurosciences & neurology (6598) 6598
rheumatology (6391) 6391
rats, wistar (6327) 6327
rats, sprague-dawley (5808) 5808
surgery (5799) 5799
arthritis (5627) 5627
cells, cultured (5517) 5517
anti-inflammatory agents, non-steroidal - chemistry (5381) 5381
anti-inflammatory agents - chemistry (5366) 5366
dermatology (5305) 5305
antioxidants (5262) 5262
arthritis, rheumatoid - drug therapy (5157) 5157
aged, 80 and over (5078) 5078
plant extracts - pharmacology (5028) 5028
cell line (5016) 5016
administration, oral (4969) 4969
medicine & public health (4904) 4904
medicine (4831) 4831
drugs (4768) 4768
prospective studies (4758) 4758
cell biology (4742) 4742
research article (4723) 4723
neurosciences (4641) 4641
retrospective studies (4502) 4502
nitric oxide (4499) 4499
young adult (4410) 4410
medical research (4409) 4409
studies (4403) 4403
patients (4345) 4345
steroids (4308) 4308
follow-up studies (4197) 4197
aspirin (4135) 4135
anti-inflammatory activity (4122) 4122
cancer (4042) 4042
oncology (3982) 3982
nf-kappa b - metabolism (3909) 3909
dosage and administration (3907) 3907
diagnosis, differential (3866) 3866
abridged index medicus (3852) 3852
corticosteroids (3847) 3847
clinical trials (3845) 3845
usage (3827) 3827
clinical neurology (3826) 3826
child, preschool (3824) 3824
medicine, research & experimental (3821) 3821
research & experimental medicine (3813) 3813
pediatrics (3790) 3790
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (170) 170
Online Resources - Online (72) 72
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
UofT at Mississauga - Stacks (6) 6
Sunnybrook Health Sciences Centre - Holland Stacks (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Scarborough - Stacks (3) 3
Gerstein Science - Periodical Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Media Commons - Audio Visual (1) 1
Mt Sinai Hospital - Online (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (186166) 186166
German (4432) 4432
French (3892) 3892
Japanese (3841) 3841
Russian (2135) 2135
Spanish (1785) 1785
Italian (1519) 1519
Chinese (1344) 1344
Portuguese (1062) 1062
Polish (751) 751
Korean (611) 611
Dutch (331) 331
Danish (286) 286
Czech (234) 234
Swedish (201) 201
Hungarian (196) 196
Romanian (186) 186
Norwegian (184) 184
Turkish (132) 132
Croatian (126) 126
Finnish (104) 104
Ukrainian (99) 99
Slovak (74) 74
Bulgarian (69) 69
Hebrew (66) 66
Serbian (51) 51
Lithuanian (24) 24
Arabic (12) 12
Persian (12) 12
Bosnian (11) 11
Slovenian (7) 7
Afrikaans (5) 5
Indonesian (5) 5
Icelandic (4) 4
Greek (3) 3
Breton (1) 1
Catalan (1) 1
Latin (1) 1
Malay (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Advances in neuroimmunology, ISSN 0960-5428, 1991
Journal
Marine drugs, ISSN 1660-3397, 07/2011, Volume 9, Issue 7, pp. 1293 - 1306
Neorogioltriol is a tricyclic brominated diterpenoid isolated from the organic extract of the red algae Laurencia glandulifera. In the present study, the... 
NF-κB | Neorogioltriol | TNFα | COX-2 | Laurencia | Carrageenan | Anti-inflammatory | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Plant Extracts - toxicity | Diterpenes - toxicity | Laurencia - chemistry | Plant Extracts - pharmacology | Lipopolysaccharides - metabolism | Anti-Inflammatory Agents, Non-Steroidal - isolation & purification | Anti-Inflammatory Agents - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Dose-Response Relationship, Drug | Plant Extracts - metabolism | Dexamethasone - pharmacology | Time Factors | Anti-Inflammatory Agents - isolation & purification | Inflammation Mediators - antagonists & inhibitors | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Aspirin - pharmacology | Diterpenes - metabolism | Phytotherapy | Inflammation Mediators - physiology | Lipopolysaccharides - physiology | Disease Models, Animal | Diterpenes - pharmacology | Cell Survival - drug effects | Anti-Inflammatory Agents - pharmacology | Anti-Inflammatory Agents - toxicity | Diterpenes - isolation & purification | Rats | Plant Extracts - isolation & purification | Edema - drug therapy | Control Groups | Anti-Inflammatory Agents, Non-Steroidal - toxicity | Macrophages - metabolism | Animals | Arthritis - drug therapy | Macrophages - drug effects | Mice | Edema - chemically induced | Anti-Inflammatory Agents, Non-Steroidal | Edema | Inflammation Mediators | Aspirin | Dexamethasone | Anti-Inflammatory Agents | Plant Extracts | Cell Survival | Arthritis | Macrophages | Lipopolysaccharides | Life Sciences | Immunology | Diterpenes | carrageenan | anti-inflammatory | neorogioltriol
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 06/2015, Volume 148, Issue 7, pp. 1320 - 1329.e3
Background & Aims Infliximab, a tumor necrosis factor antagonist, is effective for treating patients with Crohn’s disease (CD) and ulcerative colitis (UC). We... 
Gastroenterology and Hepatology | Personalized Medicine | Pharmacokinetics | Therapeutic Drug Monitoring | Monoclonal Antibody | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Drug Costs | Recurrence | Crohn Disease - economics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Male | Colitis, Ulcerative - immunology | Gastrointestinal Agents - economics | Antibodies, Monoclonal - blood | Drug Dosage Calculations | Anti-Inflammatory Agents - adverse effects | Infliximab | Crohn Disease - diagnosis | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Colitis, Ulcerative - drug therapy | Gastrointestinal Agents - pharmacokinetics | Anti-Inflammatory Agents - economics | Tertiary Care Centers | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Colitis, Ulcerative - blood | Crohn Disease - immunology | Remission Induction | Anti-Inflammatory Agents - blood | Algorithms | Belgium | Colitis, Ulcerative - diagnosis | Antibodies, Monoclonal - administration & dosage | Cost-Benefit Analysis | Crohn Disease - blood | Crohn Disease - drug therapy | Gastrointestinal Agents - adverse effects | Gastrointestinal Agents - blood | Colitis, Ulcerative - economics | Drug Monitoring | Antibodies, Monoclonal - economics | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Continuing medical education | Consulting services | Ulcerative colitis
Journal Article
Rheumatology international, ISSN 0172-8172, 2011, Volume 32, Issue 6, pp. 1491 - 1502
Journal Article
Pharmacoepidemiology and drug safety, ISSN 1053-8569, 06/2013, Volume 22, Issue 6, pp. 559 - 570
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2017, Volume 389, Issue 10087, pp. 2375 - 2382
Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Celecoxib - administration & dosage | Recurrence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Secondary Prevention - methods | Aspirin - administration & dosage | Cyclooxygenase 2 Inhibitors - adverse effects | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Aspirin - therapeutic use | Drug Therapy, Combination | Celecoxib - adverse effects | Naproxen - adverse effects | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Cyclooxygenase 2 Inhibitors - administration & dosage | Peptic Ulcer Hemorrhage - chemically induced | Celecoxib - therapeutic use | Proton Pump Inhibitors - therapeutic use | Naproxen - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Aged | Care and treatment | Aspirin | Anti-inflammatory drugs | Gastrointestinal diseases | Naproxen | Clinical trials | Arthritis | Complications and side effects | Medical research | Gastrointestinal bleeding | Medicine, Experimental | Drugs | Funding | Risk | Population studies | Hemorrhage | Evidence-based medicine | Bleeding | Incidence | Motivation | Safety | Nonsteroidal anti-inflammatory drugs | Digestive system | Risk reduction | Inflammation | Celecoxib | Patients | Anti-inflammatory agents | Diseases | Omeprazole | Random numbers | Inhibitors | Ulcers | Healing | Fatalities | Cyclooxygenase-2 | Cardiovascular diseases | Health risk assessment | Protons | Randomization | Analgesics | Endoscopy | Drug dosages | Mortality | Health risks | Hospitals
Journal Article